A live webcast of the presentation will be available on the investor section of the Anaptys website at A replay of the webcast will be available for at least 30 days following the event. About ...

Chief executive David Zaccardelli said Ohtuvayre was off to an "exceptionally strong start" with more than 3,500 healthcare ...

The global pediatric vaccine market is set for unprecedented growth, with a valuation of US$ 54,130.1 million in 2023, ...

The company is one of a few drugmakers currently developing a vaccine for the illness, which is spreading rapidly through ...

Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies ...

The FDA previously designated the ADC as a breakthrough drug for relapsed or refractory extensive-stage small-cell lung ...

Which five UK shares does ChatGPT think might be worthy of investment in 2025? Paul Summers reckons one pick might come as a ...

London: GSK plc has announced that the US Food and Drug Administration (USFDA) has granted Breakthrough Therapy Designation ...

GSK announced on Tuesday that its investigational antibody-drug conjugate GSK'227 has been granted breakthrough therapy ...

(Alliance News) - GSK PLC on Tuesday said the US Food & Drug Administration has granted a breakthrough therapy designation to its treatment for a form of bone cancer.

Stocks in London are set to open lower on Tuesday, with a eurozone inflation reading, and US data in focus. Both batches of data will be scrutinised for what they could mean for the European Central ...

Pharma companies in India are expected to report healthy earnings growth in the just-concluded October-December quarter averaging 194 per cent as per a repor ...